Protective effects of Pycnogenol on carbon tetrachloride-induced hepatotoxicity in Sprague-Dawley rats. 2008

Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
Department of Toxicology, College of Veterinary Medicine, Chonnam National University, Gwangju 500-757, Republic of Korea.

Oxidative damage is implicated in the pathogenesis of various liver injuries. In the present study the ability of Pycnogenol (PYC) as an antioxidant to protect against CCl4-induced oxidative stress and hepatotoxicity in rats was investigated. Four experimental groups of six rats each were constructed: a vehicle control group received the respective vehicles (distilled water and corn oil) only; a CCl4 group received a 14-day repeated intraperitoneal (i.p.) dose of distilled water and then a single oral dose of CCl4 at 1.25 ml/kg; and the CCl4&PYC 10 and CCl4&PYC 20 groups received a 14-day repeated i.p. dose of PYC 10 and 20 mg/kg, respectively, and then a single oral dose of CCl4 at 1.25 ml/kg. Hepatotoxicity was assessed 24 h after the CCl4 treatment by measurement of serum aminotransferase (AST) and alanine aminotransferase (ALT) activities, hepatic malondialdehyde (MDA) and glutathione (GSH) concentrations, and catalase, superoxide dismutase (SOD), and glutathione-S-transferase (GST) activities. The results were confirmed histopathologically. The single oral dose of CCl4 produced significantly elevated levels of serum AST and ALT activities. Histopathological examinations showed extensive liver injuries, characterized by extensive hepatocellular degeneration/necrosis, fatty changes, inflammatory cell infiltration, congestion, and sinusoidal dilatation. In addition, an increased MDA concentration and decreased GSH, catalase, SOD, and GST were observed in the hepatic tissues. On the contrary, PYC treatment prior to the administration of CCl4 significantly prevented the CCl4-induced hepatotoxicity, including the elevation of serum AST and ALT activities and histopathological hepatic lesions, in a dose-dependent manner. Moreover, MDA and GSH levels and catalase, SOD, and GST activities in hepatic tissues were not affected by administration of CCl4, indicating that the pretreatment of PYC efficiently protects against CCl4-induced oxidative damage in rats. The results indicate that PYC has a protective effect against acute hepatotoxicity induced by the administration of CCl4 in rats, and that the hepatoprotective effects of PYC may be due to both the inhibition of lipid peroxidation and the increase of antioxidant activity.

UI MeSH Term Description Entries
D007596 Joints Also known as articulations, these are points of connection between the ends of certain separate bones, or where the borders of other bones are juxtaposed. Joint
D010936 Plant Extracts Concentrated pharmaceutical preparations of plants obtained by removing active constituents with a suitable solvent, which is evaporated away, and adjusting the residue to a prescribed standard. Herbal Medicines,Plant Extract,Extract, Plant,Extracts, Plant,Medicines, Herbal
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D003907 Dexamethasone An anti-inflammatory 9-fluoro-glucocorticoid. Hexadecadrol,Decaject,Decaject-L.A.,Decameth,Decaspray,Dexasone,Dexpak,Hexadrol,Maxidex,Methylfluorprednisolone,Millicorten,Oradexon,Decaject L.A.
D004487 Edema Abnormal fluid accumulation in TISSUES or body cavities. Most cases of edema are present under the SKIN in SUBCUTANEOUS TISSUE. Dropsy,Hydrops,Anasarca
D005260 Female Females
D000410 Alanine Transaminase An enzyme that catalyzes the conversion of L-alanine and 2-oxoglutarate to pyruvate and L-glutamate. (From Enzyme Nomenclature, 1992) EC 2.6.1.2. Alanine Aminotransferase,Glutamic-Pyruvic Transaminase,SGPT,Alanine-2-Oxoglutarate Aminotransferase,Glutamic-Alanine Transaminase,Alanine 2 Oxoglutarate Aminotransferase,Aminotransferase, Alanine,Aminotransferase, Alanine-2-Oxoglutarate,Glutamic Alanine Transaminase,Glutamic Pyruvic Transaminase,Transaminase, Alanine,Transaminase, Glutamic-Alanine,Transaminase, Glutamic-Pyruvic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001169 Arthritis, Experimental ARTHRITIS that is induced in experimental animals. Immunological methods and infectious agents can be used to develop experimental arthritis models. These methods include injections of stimulators of the immune response, such as an adjuvant (ADJUVANTS, IMMUNOLOGIC) or COLLAGEN. Adjuvant Arthritis,Arthritis, Adjuvant-Induced,Arthritis, Collagen-Induced,Arthritis, Adjuvant,Collagen Arthritis,Arthritides, Collagen,Arthritis, Collagen,Collagen Arthritides,Collagen-Induced Arthritides,Collagen-Induced Arthritis

Related Publications

Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
April 1997, Planta medica,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
January 2016, Frontiers in pharmacology,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
August 2003, Urology,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
March 2007, Toxicology,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
January 2011, Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS),
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
May 2008, Journal of ethnopharmacology,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
December 1995, Free radical research,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
April 2001, Archives of pharmacal research,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
October 2007, Archives of pharmacal research,
Young-Su Yang, and Tai-Hwan Ahn, and Jong-Chan Lee, and Chang-Jong Moon, and Sung-Ho Kim, and Woojin Jun, and Seung-Chun Park, and Hyoung-Chin Kim, and Jong-Choon Kim
April 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
Copied contents to your clipboard!